酵素結合免疫吸附檢測法(ELISA)全球市場,2024-2028
市場調查報告書
商品編碼
1582983

酵素結合免疫吸附檢測法(ELISA)全球市場,2024-2028

Global Enzyme-linked Immunosorbent Assay (elisa) Market 2024-2028

出版日期: | 出版商: TechNavio | 英文 192 Pages | 訂單完成後即時交付

價格

酵素結合免疫吸附檢測法(ELISA)市場,2024-2028

酵素結合免疫吸附檢測法(ELISA) 市場預計在 2023 年至 2028 年期間將成長 8.439 億美元,預測期內複合年成長率為 16.82%。該報告包括對酵素結合免疫吸附檢測法(ELISA) 市場的總體分析、市場規模和預測、趨勢、成長促進因素、挑戰以及涵蓋約 25 家供應商的供應商分析。

它提供了對當前市場狀況、最新趨勢和促進因素以及整體市場環境的最新分析。老齡化社會對頻繁診斷測試的需求不斷增加、食品業毒性測試的增加以及慢性病的增加推動了該市場的發展。

市場範圍
基準年 2024年
結束年份 2028年
預測期 2024-2028
成長動力 加速度
年與前一年同期比較[2024] 14.02%
複合年成長率 16.82%
增量 8.439 億美元

研究指出,促銷活動的重要性日益增加,是推動酵素結合免疫吸附檢測法(ELISA)市場未來幾年成長的關鍵因素之一。此外,癌症患者數量的增加和新疾病標靶的出現將帶來巨大的市場需求。

目錄

第1章執行摘要

  • 市場概況

第2章 市場狀況

  • 市場生態系統
  • 市場特徵
  • 價值鏈分析

第3章 市場規模評估

  • 市場定義
  • 細分市場分析
  • 2023 年市場規模
  • 2023-2028年市場展望

第4章 市場規模表現

  • 酵素結合免疫吸附檢測法(ELISA) 全球市場 2018-2022
  • 2018-2022 年按應用分類的細分市場分析
  • 2018-2022 年最終用戶細分分析
  • 2018-2022 年區域細分分析
  • 2018-2022 年國家細分分析

第5章五力分析

  • 五力摘要
  • 買方議價能力
  • 供應商的議價能力
  • 新進入者的威脅
  • 替代品的威脅
  • 競爭威脅
  • 市場狀況

第6章 按應用程式細分市場

  • 市場區隔
  • 比較:按應用
  • 疫苗開發:2023-2028年市場規模與預測
  • 免疫學:2023-2028 年市場規模與預測
  • 診斷:市場規模及2023-2028年預測
  • 藥物警戒與製藥業:2023-2028 年市場規模與預測
  • 其他:2023-2028年市場規模與預測
  • 按應用分類的市場機會

第7章 最終用戶的市場區隔

  • 市場區隔
  • 比較:按最終用戶
  • 醫院與診斷中心:2023-2028 年市場規模與預測
  • 研究所:2023-2028年市場規模與預測
  • 其他:2023-2028年市場規模與預測
  • 最終用戶的市場機會

第8章 客戶狀況

  • 客戶狀況概覽

第9章 地區情勢

  • 區域細分
  • 比較:按地區
  • 北美:2023-2028 年市場規模與預測
  • 歐洲:2023-2028 年市場規模與預測
  • 亞洲:2023-2028年市場規模與預測
  • 其他:2023-2028年市場規模與預測
  • 美國:2023-2028 年市場規模與預測
  • 中國:2023-2028年市場規模及預測
  • 英國:2023-2028 年市場規模與預測
  • 德國:2023-2028 年市場規模與預測
  • 日本:2023-2028年市場規模與預測
  • 按區域情況分類的市場機會

第10章 促進因素、挑戰、機會、限制因素

  • 市場促進因素
  • 市場問題
  • 促進因素和挑戰的影響
  • 市場機會/限制

第11章競爭格局

  • 概述
  • 競爭格局
  • 混亂的情況
  • 產業風險

第12章 競爭分析

  • 公司簡介
  • 公司市場定位
  • Abbott Laboratories
  • Abcam plc
  • Agilent Technologies Inc.
  • Avantor Inc.
  • Becton Dickinson and Co.
  • Bio Rad Laboratories Inc.
  • bioMerieux SA
  • Danaher Corp.
  • Eppendorf SE
  • Merck KGaA
  • Novo Nordisk AS
  • Perkin Elmer Inc.
  • QIAGEN NV
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.

第13章附錄

Product Code: IRTNTR41149

Enzyme-linked Immunosorbent Assay (ELISA) Market 2024-2028

The enzyme-linked immunosorbent assay (ELISA) market is forecasted to grow by USD 843.9 mn during 2023-2028, accelerating at a CAGR of 16.82% during the forecast period. The report on the enzyme-linked immunosorbent assay (ELISA) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing need for frequent diagnostic testing among aging population, rise in toxicology testing in food industry, and increase in chronic diseases.

Market Scope
Base Year2024
End Year2028
Series Year2024-2028
Growth MomentumAccelerate
YOY 202414.02%
CAGR16.82%
Incremental Value$843.9 mn

Technavio's enzyme-linked immunosorbent assay (ELISA) market is segmented as below:

By Application

    • Vaccine development
    • Immunology
    • Diagnostics
    • Drug monitoring and pharmaceutical industry
    • Others

By End-user

    • Hospitals and diagnostic centers
    • Research laboratories
    • Others

By Geographical Landscape

    • North America
    • Europe
    • Asia
    • Rest of World (ROW)

This study identifies the growing importance of promotional activities as one of the prime reasons driving the enzyme-linked immunosorbent assay (ELISA) market growth during the next few years. Also, increasing cases of cancer and emergence of new disease targets will lead to sizable demand in the market.

The report on the enzyme-linked immunosorbent assay (ELISA) market covers the following areas:

    • Enzyme-linked immunosorbent assay (ELISA) market sizing
    • Enzyme-linked immunosorbent assay (ELISA) market forecast
    • Enzyme-linked immunosorbent assay (ELISA) market industry analysis

The strong vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading enzyme-linked immunosorbent assay (ELISA) market vendors that include Abbott Laboratories, Abcam PLC, Agilent Technologies Inc., Amgen Inc., Avantor Inc., Becton Dickinson and Co., Bio RAD Laboratories Inc., bioMerieux SA, Cardinal Health Inc., Crux Biolabs Pty Ltd., Danaher Corp., Eppendorf SE, Illumina Inc., Lonza Group Ltd., Merck KGaA, Novo Nordisk AS, Perkin Elmer Inc., QIAGEN NV, Siemens Healthineers AG, and Thermo Fisher Scientific Inc.. Also, the enzyme-linked immunosorbent assay (ELISA) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market By Geographical Landscape
    • Executive Summary - Chart on Market Segmentation by Application
    • Executive Summary - Chart on Market Segmentation by End-user
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Parent Market
    • Data Table on - Parent Market
  • 2.2 Market characteristics
    • Market characteristics analysis
  • 2.3 Value chain analysis
    • Value Chain Analysis

3 Market Sizing

  • 3.1 Market definition
    • Offerings of companies included in the market definition
  • 3.2 Market segment analysis
    • Market segments
  • 3.3 Market size 2023
  • 3.4 Market outlook: Forecast for 2023-2028
    • Chart on Global - Market size and forecast 2023-2028 ($ million)
    • Data Table on Global - Market size and forecast 2023-2028 ($ million)
    • Chart on Global Market: Year-over-year growth 2023-2028 (%)
    • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

  • 4.1 Global Enzyme-Linked Immunosorbent Assay (Elisa) Market 2018 - 2022
    • Historic Market Size - Data Table on Global Enzyme-Linked Immunosorbent Assay (Elisa) Market 2018 - 2022 ($ million)
  • 4.2 Application segment analysis 2018 - 2022
    • Historic Market Size - Application Segment 2018 - 2022 ($ million)
  • 4.3 End-user segment analysis 2018 - 2022
    • Historic Market Size - End-user Segment 2018 - 2022 ($ million)
  • 4.4 Geography segment analysis 2018 - 2022
    • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
  • 4.5 Country segment analysis 2018 - 2022
    • Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

  • 5.1 Five forces summary
    • Five forces analysis - Comparison between 2023 and 2028
  • 5.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2023 and 2028
  • 5.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • 5.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2023 and 2028
  • 5.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2023 and 2028
  • 5.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2023 and 2028
  • 5.7 Market condition
    • Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Application

  • 6.1 Market segments
    • Chart on Application - Market share 2023-2028 (%)
    • Data Table on Application - Market share 2023-2028 (%)
  • 6.2 Comparison by Application
    • Chart on Comparison by Application
    • Data Table on Comparison by Application
  • 6.3 Vaccine development - Market size and forecast 2023-2028
    • Chart on Vaccine development - Market size and forecast 2023-2028 ($ million)
    • Data Table on Vaccine development - Market size and forecast 2023-2028 ($ million)
    • Chart on Vaccine development - Year-over-year growth 2023-2028 (%)
    • Data Table on Vaccine development - Year-over-year growth 2023-2028 (%)
  • 6.4 Immunology - Market size and forecast 2023-2028
    • Chart on Immunology - Market size and forecast 2023-2028 ($ million)
    • Data Table on Immunology - Market size and forecast 2023-2028 ($ million)
    • Chart on Immunology - Year-over-year growth 2023-2028 (%)
    • Data Table on Immunology - Year-over-year growth 2023-2028 (%)
  • 6.5 Diagnostics - Market size and forecast 2023-2028
    • Chart on Diagnostics - Market size and forecast 2023-2028 ($ million)
    • Data Table on Diagnostics - Market size and forecast 2023-2028 ($ million)
    • Chart on Diagnostics - Year-over-year growth 2023-2028 (%)
    • Data Table on Diagnostics - Year-over-year growth 2023-2028 (%)
  • 6.6 Drug monitoring and pharmaceutical industry - Market size and forecast 2023-2028
    • Chart on Drug monitoring and pharmaceutical industry - Market size and forecast 2023-2028 ($ million)
    • Data Table on Drug monitoring and pharmaceutical industry - Market size and forecast 2023-2028 ($ million)
    • Chart on Drug monitoring and pharmaceutical industry - Year-over-year growth 2023-2028 (%)
    • Data Table on Drug monitoring and pharmaceutical industry - Year-over-year growth 2023-2028 (%)
  • 6.7 Others - Market size and forecast 2023-2028
    • Chart on Others - Market size and forecast 2023-2028 ($ million)
    • Data Table on Others - Market size and forecast 2023-2028 ($ million)
    • Chart on Others - Year-over-year growth 2023-2028 (%)
    • Data Table on Others - Year-over-year growth 2023-2028 (%)
  • 6.8 Market opportunity by Application
    • Market opportunity by Application ($ million)
    • Data Table on Market opportunity by Application ($ million)

7 Market Segmentation by End-user

  • 7.1 Market segments
    • Chart on End-user - Market share 2023-2028 (%)
    • Data Table on End-user - Market share 2023-2028 (%)
  • 7.2 Comparison by End-user
    • Chart on Comparison by End-user
    • Data Table on Comparison by End-user
  • 7.3 Hospitals and diagnostic centers - Market size and forecast 2023-2028
    • Chart on Hospitals and diagnostic centers - Market size and forecast 2023-2028 ($ million)
    • Data Table on Hospitals and diagnostic centers - Market size and forecast 2023-2028 ($ million)
    • Chart on Hospitals and diagnostic centers - Year-over-year growth 2023-2028 (%)
    • Data Table on Hospitals and diagnostic centers - Year-over-year growth 2023-2028 (%)
  • 7.4 Research laboratories - Market size and forecast 2023-2028
    • Chart on Research laboratories - Market size and forecast 2023-2028 ($ million)
    • Data Table on Research laboratories - Market size and forecast 2023-2028 ($ million)
    • Chart on Research laboratories - Year-over-year growth 2023-2028 (%)
    • Data Table on Research laboratories - Year-over-year growth 2023-2028 (%)
  • 7.5 Others - Market size and forecast 2023-2028
    • Chart on Others - Market size and forecast 2023-2028 ($ million)
    • Data Table on Others - Market size and forecast 2023-2028 ($ million)
    • Chart on Others - Year-over-year growth 2023-2028 (%)
    • Data Table on Others - Year-over-year growth 2023-2028 (%)
  • 7.6 Market opportunity by End-user
    • Market opportunity by End-user ($ million)
    • Data Table on Market opportunity by End-user ($ million)

8 Customer Landscape

  • 8.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
    • Chart on Market share By Geographical Landscape 2023-2028 (%)
    • Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • 9.2 Geographic comparison
    • Chart on Geographic comparison
    • Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2023-2028
    • Chart on North America - Market size and forecast 2023-2028 ($ million)
    • Data Table on North America - Market size and forecast 2023-2028 ($ million)
    • Chart on North America - Year-over-year growth 2023-2028 (%)
    • Data Table on North America - Year-over-year growth 2023-2028 (%)
  • 9.4 Europe - Market size and forecast 2023-2028
    • Chart on Europe - Market size and forecast 2023-2028 ($ million)
    • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
    • Chart on Europe - Year-over-year growth 2023-2028 (%)
    • Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • 9.5 Asia - Market size and forecast 2023-2028
    • Chart on Asia - Market size and forecast 2023-2028 ($ million)
    • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
    • Chart on Asia - Year-over-year growth 2023-2028 (%)
    • Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
    • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
    • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
    • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • 9.7 US - Market size and forecast 2023-2028
    • Chart on US - Market size and forecast 2023-2028 ($ million)
    • Data Table on US - Market size and forecast 2023-2028 ($ million)
    • Chart on US - Year-over-year growth 2023-2028 (%)
    • Data Table on US - Year-over-year growth 2023-2028 (%)
  • 9.8 China - Market size and forecast 2023-2028
    • Chart on China - Market size and forecast 2023-2028 ($ million)
    • Data Table on China - Market size and forecast 2023-2028 ($ million)
    • Chart on China - Year-over-year growth 2023-2028 (%)
    • Data Table on China - Year-over-year growth 2023-2028 (%)
  • 9.9 UK - Market size and forecast 2023-2028
    • Chart on UK - Market size and forecast 2023-2028 ($ million)
    • Data Table on UK - Market size and forecast 2023-2028 ($ million)
    • Chart on UK - Year-over-year growth 2023-2028 (%)
    • Data Table on UK - Year-over-year growth 2023-2028 (%)
  • 9.10 Germany - Market size and forecast 2023-2028
    • Chart on Germany - Market size and forecast 2023-2028 ($ million)
    • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
    • Chart on Germany - Year-over-year growth 2023-2028 (%)
    • Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • 9.11 Japan - Market size and forecast 2023-2028
    • Chart on Japan - Market size and forecast 2023-2028 ($ million)
    • Data Table on Japan - Market size and forecast 2023-2028 ($ million)
    • Chart on Japan - Year-over-year growth 2023-2028 (%)
    • Data Table on Japan - Year-over-year growth 2023-2028 (%)
  • 9.12 Market opportunity By Geographical Landscape
    • Market opportunity By Geographical Landscape ($ million)
    • Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Opportunity/Restraints

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2023 and 2028
  • 10.4 Market opportunities/restraints

11 Competitive Landscape

  • 11.1 Overview
  • 11.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 11.3 Landscape disruption
    • Overview on factors of disruption
  • 11.4 Industry risks
    • Impact of key risks on business

12 Competitive Analysis

  • 12.1 Companies profiled
    • Companies covered
  • 12.2 Market positioning of companies
    • Matrix on companies position and classification
  • 12.3 Abbott Laboratories
    • Abbott Laboratories - Overview
    • Abbott Laboratories - Business segments
    • Abbott Laboratories - Key news
    • Abbott Laboratories - Key offerings
    • Abbott Laboratories - Segment focus
  • 12.4 Abcam plc
    • Abcam plc - Overview
    • Abcam plc - Product / Service
    • Abcam plc - Key news
    • Abcam plc - Key offerings
  • 12.5 Agilent Technologies Inc.
    • Agilent Technologies Inc. - Overview
    • Agilent Technologies Inc. - Business segments
    • Agilent Technologies Inc. - Key news
    • Agilent Technologies Inc. - Key offerings
    • Agilent Technologies Inc. - Segment focus
  • 12.6 Avantor Inc.
    • Avantor Inc. - Overview
    • Avantor Inc. - Business segments
    • Avantor Inc. - Key news
    • Avantor Inc. - Key offerings
    • Avantor Inc. - Segment focus
  • 12.7 Becton Dickinson and Co.
    • Becton Dickinson and Co. - Overview
    • Becton Dickinson and Co. - Business segments
    • Becton Dickinson and Co. - Key news
    • Becton Dickinson and Co. - Key offerings
    • Becton Dickinson and Co. - Segment focus
  • 12.8 Bio Rad Laboratories Inc.
    • Bio Rad Laboratories Inc. - Overview
    • Bio Rad Laboratories Inc. - Business segments
    • Bio Rad Laboratories Inc. - Key news
    • Bio Rad Laboratories Inc. - Key offerings
    • Bio Rad Laboratories Inc. - Segment focus
  • 12.9 bioMerieux SA
    • bioMerieux SA - Overview
    • bioMerieux SA - Product / Service
    • bioMerieux SA - Key news
    • bioMerieux SA - Key offerings
  • 12.10 Danaher Corp.
    • Danaher Corp. - Overview
    • Danaher Corp. - Business segments
    • Danaher Corp. - Key news
    • Danaher Corp. - Key offerings
    • Danaher Corp. - Segment focus
  • 12.11 Eppendorf SE
    • Eppendorf SE - Overview
    • Eppendorf SE - Product / Service
    • Eppendorf SE - Key news
    • Eppendorf SE - Key offerings
  • 12.12 Merck KGaA
    • Merck KGaA - Overview
    • Merck KGaA - Business segments
    • Merck KGaA - Key news
    • Merck KGaA - Key offerings
    • Merck KGaA - Segment focus
  • 12.13 Novo Nordisk AS
    • Novo Nordisk AS - Overview
    • Novo Nordisk AS - Business segments
    • Novo Nordisk AS - Key news
    • Novo Nordisk AS - Key offerings
    • Novo Nordisk AS - Segment focus
  • 12.14 Perkin Elmer Inc.
    • Perkin Elmer Inc. - Overview
    • Perkin Elmer Inc. - Business segments
    • Perkin Elmer Inc. - Key news
    • Perkin Elmer Inc. - Key offerings
    • Perkin Elmer Inc. - Segment focus
  • 12.15 QIAGEN NV
    • QIAGEN NV - Overview
    • QIAGEN NV - Product / Service
    • QIAGEN NV - Key news
    • QIAGEN NV - Key offerings
  • 12.16 Siemens Healthineers AG
    • Siemens Healthineers AG - Overview
    • Siemens Healthineers AG - Business segments
    • Siemens Healthineers AG - Key news
    • Siemens Healthineers AG - Key offerings
    • Siemens Healthineers AG - Segment focus
  • 12.17 Thermo Fisher Scientific Inc.
    • Thermo Fisher Scientific Inc. - Overview
    • Thermo Fisher Scientific Inc. - Business segments
    • Thermo Fisher Scientific Inc. - Key news
    • Thermo Fisher Scientific Inc. - Key offerings
    • Thermo Fisher Scientific Inc. - Segment focus

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 13.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 13.4 Research methodology
    • Research methodology
  • 13.5 Data procurement
    • Information sources
  • 13.6 Data validation
    • Data validation
  • 13.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 13.8 Data synthesis
    • Data synthesis
  • 13.9 360 degree market analysis
    • 360 degree market analysis
  • 13.10 List of abbreviations
    • List of abbreviations

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Application
  • Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibits7: Executive Summary - Chart on Incremental Growth
  • Exhibits8: Executive Summary - Data Table on Incremental Growth
  • Exhibits9: Executive Summary - Chart on Company Market Positioning
  • Exhibits10: Parent Market
  • Exhibits11: Data Table on - Parent Market
  • Exhibits12: Market characteristics analysis
  • Exhibits13: Value Chain Analysis
  • Exhibits14: Offerings of companies included in the market definition
  • Exhibits15: Market segments
  • Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits20: Historic Market Size - Data Table on Global Enzyme-Linked Immunosorbent Assay (Elisa) Market 2018 - 2022 ($ million)
  • Exhibits21: Historic Market Size - Application Segment 2018 - 2022 ($ million)
  • Exhibits22: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
  • Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
  • Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
  • Exhibits25: Five forces analysis - Comparison between 2023 and 2028
  • Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
  • Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
  • Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
  • Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
  • Exhibits31: Chart on Market condition - Five forces 2023 and 2028
  • Exhibits32: Chart on Application - Market share 2023-2028 (%)
  • Exhibits33: Data Table on Application - Market share 2023-2028 (%)
  • Exhibits34: Chart on Comparison by Application
  • Exhibits35: Data Table on Comparison by Application
  • Exhibits36: Chart on Vaccine development - Market size and forecast 2023-2028 ($ million)
  • Exhibits37: Data Table on Vaccine development - Market size and forecast 2023-2028 ($ million)
  • Exhibits38: Chart on Vaccine development - Year-over-year growth 2023-2028 (%)
  • Exhibits39: Data Table on Vaccine development - Year-over-year growth 2023-2028 (%)
  • Exhibits40: Chart on Immunology - Market size and forecast 2023-2028 ($ million)
  • Exhibits41: Data Table on Immunology - Market size and forecast 2023-2028 ($ million)
  • Exhibits42: Chart on Immunology - Year-over-year growth 2023-2028 (%)
  • Exhibits43: Data Table on Immunology - Year-over-year growth 2023-2028 (%)
  • Exhibits44: Chart on Diagnostics - Market size and forecast 2023-2028 ($ million)
  • Exhibits45: Data Table on Diagnostics - Market size and forecast 2023-2028 ($ million)
  • Exhibits46: Chart on Diagnostics - Year-over-year growth 2023-2028 (%)
  • Exhibits47: Data Table on Diagnostics - Year-over-year growth 2023-2028 (%)
  • Exhibits48: Chart on Drug monitoring and pharmaceutical industry - Market size and forecast 2023-2028 ($ million)
  • Exhibits49: Data Table on Drug monitoring and pharmaceutical industry - Market size and forecast 2023-2028 ($ million)
  • Exhibits50: Chart on Drug monitoring and pharmaceutical industry - Year-over-year growth 2023-2028 (%)
  • Exhibits51: Data Table on Drug monitoring and pharmaceutical industry - Year-over-year growth 2023-2028 (%)
  • Exhibits52: Chart on Others - Market size and forecast 2023-2028 ($ million)
  • Exhibits53: Data Table on Others - Market size and forecast 2023-2028 ($ million)
  • Exhibits54: Chart on Others - Year-over-year growth 2023-2028 (%)
  • Exhibits55: Data Table on Others - Year-over-year growth 2023-2028 (%)
  • Exhibits56: Market opportunity by Application ($ million)
  • Exhibits57: Data Table on Market opportunity by Application ($ million)
  • Exhibits58: Chart on End-user - Market share 2023-2028 (%)
  • Exhibits59: Data Table on End-user - Market share 2023-2028 (%)
  • Exhibits60: Chart on Comparison by End-user
  • Exhibits61: Data Table on Comparison by End-user
  • Exhibits62: Chart on Hospitals and diagnostic centers - Market size and forecast 2023-2028 ($ million)
  • Exhibits63: Data Table on Hospitals and diagnostic centers - Market size and forecast 2023-2028 ($ million)
  • Exhibits64: Chart on Hospitals and diagnostic centers - Year-over-year growth 2023-2028 (%)
  • Exhibits65: Data Table on Hospitals and diagnostic centers - Year-over-year growth 2023-2028 (%)
  • Exhibits66: Chart on Research laboratories - Market size and forecast 2023-2028 ($ million)
  • Exhibits67: Data Table on Research laboratories - Market size and forecast 2023-2028 ($ million)
  • Exhibits68: Chart on Research laboratories - Year-over-year growth 2023-2028 (%)
  • Exhibits69: Data Table on Research laboratories - Year-over-year growth 2023-2028 (%)
  • Exhibits70: Chart on Others - Market size and forecast 2023-2028 ($ million)
  • Exhibits71: Data Table on Others - Market size and forecast 2023-2028 ($ million)
  • Exhibits72: Chart on Others - Year-over-year growth 2023-2028 (%)
  • Exhibits73: Data Table on Others - Year-over-year growth 2023-2028 (%)
  • Exhibits74: Market opportunity by End-user ($ million)
  • Exhibits75: Data Table on Market opportunity by End-user ($ million)
  • Exhibits76: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits77: Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits78: Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits79: Chart on Geographic comparison
  • Exhibits80: Data Table on Geographic comparison
  • Exhibits81: Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibits82: Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibits83: Chart on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits84: Data Table on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits85: Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibits86: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibits87: Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits88: Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits89: Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibits90: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibits91: Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits92: Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits93: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibits94: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibits95: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits96: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits97: Chart on US - Market size and forecast 2023-2028 ($ million)
  • Exhibits98: Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Exhibits99: Chart on US - Year-over-year growth 2023-2028 (%)
  • Exhibits100: Data Table on US - Year-over-year growth 2023-2028 (%)
  • Exhibits101: Chart on China - Market size and forecast 2023-2028 ($ million)
  • Exhibits102: Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Exhibits103: Chart on China - Year-over-year growth 2023-2028 (%)
  • Exhibits104: Data Table on China - Year-over-year growth 2023-2028 (%)
  • Exhibits105: Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Exhibits106: Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Exhibits107: Chart on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits108: Data Table on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits109: Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Exhibits110: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Exhibits111: Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits112: Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits113: Chart on Japan - Market size and forecast 2023-2028 ($ million)
  • Exhibits114: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
  • Exhibits115: Chart on Japan - Year-over-year growth 2023-2028 (%)
  • Exhibits116: Data Table on Japan - Year-over-year growth 2023-2028 (%)
  • Exhibits117: Market opportunity By Geographical Landscape ($ million)
  • Exhibits118: Data Tables on Market opportunity By Geographical Landscape ($ million)
  • Exhibits119: Impact of drivers and challenges in 2023 and 2028
  • Exhibits120: Overview on criticality of inputs and factors of differentiation
  • Exhibits121: Overview on factors of disruption
  • Exhibits122: Impact of key risks on business
  • Exhibits123: Companies covered
  • Exhibits124: Matrix on companies position and classification
  • Exhibits125: Abbott Laboratories - Overview
  • Exhibits126: Abbott Laboratories - Business segments
  • Exhibits127: Abbott Laboratories - Key news
  • Exhibits128: Abbott Laboratories - Key offerings
  • Exhibits129: Abbott Laboratories - Segment focus
  • Exhibits130: Abcam plc - Overview
  • Exhibits131: Abcam plc - Product / Service
  • Exhibits132: Abcam plc - Key news
  • Exhibits133: Abcam plc - Key offerings
  • Exhibits134: Agilent Technologies Inc. - Overview
  • Exhibits135: Agilent Technologies Inc. - Business segments
  • Exhibits136: Agilent Technologies Inc. - Key news
  • Exhibits137: Agilent Technologies Inc. - Key offerings
  • Exhibits138: Agilent Technologies Inc. - Segment focus
  • Exhibits139: Avantor Inc. - Overview
  • Exhibits140: Avantor Inc. - Business segments
  • Exhibits141: Avantor Inc. - Key news
  • Exhibits142: Avantor Inc. - Key offerings
  • Exhibits143: Avantor Inc. - Segment focus
  • Exhibits144: Becton Dickinson and Co. - Overview
  • Exhibits145: Becton Dickinson and Co. - Business segments
  • Exhibits146: Becton Dickinson and Co. - Key news
  • Exhibits147: Becton Dickinson and Co. - Key offerings
  • Exhibits148: Becton Dickinson and Co. - Segment focus
  • Exhibits149: Bio Rad Laboratories Inc. - Overview
  • Exhibits150: Bio Rad Laboratories Inc. - Business segments
  • Exhibits151: Bio Rad Laboratories Inc. - Key news
  • Exhibits152: Bio Rad Laboratories Inc. - Key offerings
  • Exhibits153: Bio Rad Laboratories Inc. - Segment focus
  • Exhibits154: bioMerieux SA - Overview
  • Exhibits155: bioMerieux SA - Product / Service
  • Exhibits156: bioMerieux SA - Key news
  • Exhibits157: bioMerieux SA - Key offerings
  • Exhibits158: Danaher Corp. - Overview
  • Exhibits159: Danaher Corp. - Business segments
  • Exhibits160: Danaher Corp. - Key news
  • Exhibits161: Danaher Corp. - Key offerings
  • Exhibits162: Danaher Corp. - Segment focus
  • Exhibits163: Eppendorf SE - Overview
  • Exhibits164: Eppendorf SE - Product / Service
  • Exhibits165: Eppendorf SE - Key news
  • Exhibits166: Eppendorf SE - Key offerings
  • Exhibits167: Merck KGaA - Overview
  • Exhibits168: Merck KGaA - Business segments
  • Exhibits169: Merck KGaA - Key news
  • Exhibits170: Merck KGaA - Key offerings
  • Exhibits171: Merck KGaA - Segment focus
  • Exhibits172: Novo Nordisk AS - Overview
  • Exhibits173: Novo Nordisk AS - Business segments
  • Exhibits174: Novo Nordisk AS - Key news
  • Exhibits175: Novo Nordisk AS - Key offerings
  • Exhibits176: Novo Nordisk AS - Segment focus
  • Exhibits177: Perkin Elmer Inc. - Overview
  • Exhibits178: Perkin Elmer Inc. - Business segments
  • Exhibits179: Perkin Elmer Inc. - Key news
  • Exhibits180: Perkin Elmer Inc. - Key offerings
  • Exhibits181: Perkin Elmer Inc. - Segment focus
  • Exhibits182: QIAGEN NV - Overview
  • Exhibits183: QIAGEN NV - Product / Service
  • Exhibits184: QIAGEN NV - Key news
  • Exhibits185: QIAGEN NV - Key offerings
  • Exhibits186: Siemens Healthineers AG - Overview
  • Exhibits187: Siemens Healthineers AG - Business segments
  • Exhibits188: Siemens Healthineers AG - Key news
  • Exhibits189: Siemens Healthineers AG - Key offerings
  • Exhibits190: Siemens Healthineers AG - Segment focus
  • Exhibits191: Thermo Fisher Scientific Inc. - Overview
  • Exhibits192: Thermo Fisher Scientific Inc. - Business segments
  • Exhibits193: Thermo Fisher Scientific Inc. - Key news
  • Exhibits194: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibits195: Thermo Fisher Scientific Inc. - Segment focus
  • Exhibits196: Inclusions checklist
  • Exhibits197: Exclusions checklist
  • Exhibits198: Currency conversion rates for US$
  • Exhibits199: Research methodology
  • Exhibits200: Information sources
  • Exhibits201: Data validation
  • Exhibits202: Validation techniques employed for market sizing
  • Exhibits203: Data synthesis
  • Exhibits204: 360 degree market analysis
  • Exhibits205: List of abbreviations